667. Deputy John Paul Phelan asked the Minister for Health the total expenditure for reimbursement of continuous glucose monitors on the approved medical device list for the years 2020, 2021, 2022, 2023, and 2024; and if he will make a statement on the matter. [41425/24]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.